Showing results (81-90 of 835) with videos related to
Sort By:
Pageof 84
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2006
A 24-phenylsulfone analog of vitamin D inhibits 1alpha,25-dihydroxyvitamin D(3) degradation in vitamin D metabolism-competent cellsDaniel Lechner, Teresa Manhardt, Erika Bajna, et al.Organic Letters|September 22, 2010
α-Chloro-β,γ-ethylenic esters: enantiocontrolled synthesis and substitutionsDouglas T Genna, Christopher P Hencken, Maxime A Siegler, et al.Neurology|January 15, 2000
Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled studyN Sacktor, G Schifitto, M P McDermott, et al.Archives of Neurology|April 6, 1999
Progression of parkinsonian signs in Parkinson diseaseE D Louis, M X Tang, L Cote, et al.The American Journal of Psychiatry|May 1, 1997
Association of subjective memory complaints with subsequent cognitive decline in community-dwelling elderly individuals with baseline cognitive impairmentP W Schofield, K Marder, G Dooneief, et al.Neurology|September 1, 1995
Neuropsychological characteristics of preclinical dementia in Parkinson's diseaseD M Jacobs, K Marder, L J Côté, et al.Neurology|September 17, 1999
Influence of APOE genotype on familial aggregation of AD in an urban populationG Devi, R Ottman, M Tang, et al.Neurology|March 1, 1995
Neuropsychological changes in a prospectively followed cohort of homosexual and bisexual men with and without HIV infectionY Stern, X Liu, K Marder, et al.Genetic Epidemiology|May 21, 1998
Validity of family history for the diagnosis of dementia among siblings of patients with late-onset Alzheimer's diseaseG Devi, K Marder, P W Schofield, et al.Archives of Neurology|March 1, 1988
An estimate of the prevalence of dementia in idiopathic Parkinson's diseaseR Mayeux, Y Stern, R Rosenstein, et al.Pageof 84